Role of bone marrow activity in the context of chronic diseases in cardiac MRI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033238

Enrollment

400

Registered

2024-09-24

Start date

2023-10-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I25.9 I21.9 I42.9 I40.9 I11.0 I49.9 I31.9 U09.9

Interventions

Group 1: Cardiac MRI examinations are performed according to clinical indication. Patients are divided into the following groups based on their underlying disease: Patients with ischemic heart disease

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male and female patients > 18 years of age with CMR within the last 12 months and diagnosed diseases such as: Acute perimyocarditis, chronic perimyocarditis, post-COVID syndrome, chronic coronary heart disease, previous myocardial infarction, arterial hypertension and hypertensive heart disease, diabetes mellitus

Exclusion criteria

Exclusion criteria: Patients without CMR due to contraindications or non-examination, for example due to claustrophobia or cerclage after sternotomy

Design outcomes

Primary

Measure	Time frame
The primary endpoint is CMR parameters, in particular T2 and T1 values of the patients in the above-mentioned study groups, in order to analyze differences between acute and chronic diseases.	—

Secondary

Measure	Time frame
The secondary endpoint is laboratory values of inflammation in the patients of the above-mentioned study groups.	—

Countries

Germany

Contacts

Public ContactNadine Abanador-Kamper

HELIOS Universitätsklinikum Wuppertal

nadine.abandor@helios-gesundheit.de0202 896 5692

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026